$0.6578
-0.0316-4.58%
Last update: Oct 12, 4:00 PM
$0.6860
-0.0034-0.49%
Standard BioTools Inc (LAB) Stock Price, Quote, News & History
LABNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Standard BioTools (NASDAQ:LAB) through any online brokerage.
Other companies in Standard BioTools’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Standard BioTools has a consensus price target of $2.37.
The stock price for Standard BioTools (NASDAQ: LAB) is $0.6578 last updated October 12, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Standard BioTools.
Standard BioTools does not have any upcoming earnings scheduled.
There is no upcoming split for Standard BioTools.
Standard BioTools is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and...
